Journal article
A phase II study evaluating the safety and efficacy of patupilone in patients with platinum refractory/resistant ovarian, primary fallopian, or peritoneal cancer
Abstract
5563
Authors
Smit WM; Sufliarsky J; Werner TL; Dizon D; Wagnerova M; Hirte HW; Delaney R; Li J; Weber D; Schellens JH
Journal
Journal of Clinical Oncology, Vol. 27, No. 15_suppl, pp. 5563–5563
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2009
DOI
10.1200/jco.2009.27.15_suppl.5563
ISSN
0732-183X